Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 1983;305(5930):153–155. doi: 10.1038/305153a0

Defective translation of measles virus matrix protein in a subacute sclerosing panencephalitis cell line

Michael J Carter 1, Margaret M Willcocks 1, Volker ter Meulen 1
PMCID: PMC7094927  PMID: 6888557

Abstract

Subacute sclerosing panencephalitis (SSPE) is a slowly progressing fatal human disease of the central nervous system (CNS) that is associated with measles virus persistence. Virus nucleocapsids are present in the brain1,2 and the patient is in a state of hyperimmunization towards this agent. However, although all other structural polypeptides are recognized by the immune system, there is a markedly decreased antibody response towards virus matrix or membrane protein3,4. Matrix protein has not been detected in brain cells5 and infectious virus is not present. The absence of this virus structural polypeptide is thought to account for the apparent restriction in virus maturation both in vivo and in vitro. SSPE viruses can only rarely be rescued from brain tissue by co-cultivation or cell fusion techniques using tissue culture cell lines susceptible to measles virus infection6. Often this procedure fails to yield a lytic budding virus but produces instead a carrier cell line in which the agent is cell associated. These lines (known as SSPE cell lines) also do not contain matrix protein7,8. However, the reason for this deficiency is unknown. We have therefore now examined an SSPE cell line which does not yield infectious virus in order to define this process further. We found that although messenger RNA for membrane protein was present, it was unable to form normal matrix protein in translation reactions.

References

  • 1.Conolly JH, Allen IV, Hurwitz LJ, Miller JHD. Lancet. 1967;i:542–544. doi: 10.1016/S0140-6736(67)92117-4. [DOI] [PubMed] [Google Scholar]
  • 2.Freeman JM, Magoffin RL, Lennette EH, Herndon RM. Lancet. 1967;ii:129–131. doi: 10.1016/S0140-6736(67)92965-0. [DOI] [PubMed] [Google Scholar]
  • 3.Hall WW, Lamb RA, Choppin PW. Proc. natn. Acad. Sci. U.S.A. 1979;76:2047–2051. doi: 10.1073/pnas.76.4.2047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Wechsler SL, Weiner HL, Fields BN. J. Immun. 1979;123:884–889. [PubMed] [Google Scholar]
  • 5.Hall WW, Choppin PW. Virology. 1979;99:443–447. doi: 10.1016/0042-6822(79)90026-6. [DOI] [PubMed] [Google Scholar]
  • 6.Katz M, Koprowski H. Arch. ges. Virusforsch. 1973;41:390–393. doi: 10.1007/BF01250213. [DOI] [PubMed] [Google Scholar]
  • 7.Lin FH, Thormar H. Nature. 1980;285:490–492. doi: 10.1038/285490a0. [DOI] [PubMed] [Google Scholar]
  • 8.Machamer CE, Hayes EC, Zweeringk HJ. Virology. 1981;108:515–520. doi: 10.1016/0042-6822(81)90460-8. [DOI] [PubMed] [Google Scholar]
  • 9.Doi Y. Jap. J. med. Sci. Biol. 1972;25:321–333. doi: 10.7883/yoken1952.25.321. [DOI] [PubMed] [Google Scholar]
  • 10.Ohuchi M, Ohuchi R, Homma M. Microbiol. Immun. 1979;23:877–888. doi: 10.1111/j.1348-0421.1979.tb02821.x. [DOI] [PubMed] [Google Scholar]
  • 11.Ohuchi M, Ohuchi R, Homma M. Microbiol. Immun. 1980;24:1023–1033. doi: 10.1111/j.1348-0421.1980.tb02908.x. [DOI] [PubMed] [Google Scholar]
  • 12.Dubois-Dalcq M, Horta-Barbosa L, Hamilton R, Sever JL. Lab. Invest. 1974;30:214–250. [PubMed] [Google Scholar]
  • 13.Rima BK, Lappin SA, Roberts MW, Martin SJ. J. gen. Virol. 1981;56:447–450. doi: 10.1099/0022-1317-56-2-447. [DOI] [PubMed] [Google Scholar]
  • 14.Carter, M. J. & ter Meulen, V. Brain Res.59, (in the press).
  • 15.Stephenson JR, Siddell SG, ter Meulen V. J. gen. Virol. 1981;57:191–197. doi: 10.1099/0022-1317-57-1-191. [DOI] [PubMed] [Google Scholar]
  • 16.Norrby E. Arch. ges. Virusforsch. 1967;20:215–224. doi: 10.1007/BF01241275. [DOI] [PubMed] [Google Scholar]
  • 17.Roux L, Waldvogel FA. Cell. 1982;28:293–302. doi: 10.1016/0092-8674(82)90347-6. [DOI] [PubMed] [Google Scholar]
  • 18.Gorezki M, Rozenblatt S. Proc. natn. Acad. Sci. U.S.A. 1980;77:3686–3690. doi: 10.1073/pnas.77.6.3686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Rozenblatt S, Gesang C, Lavie V, Neumann FS. J. Virol. 1982;42:790–797. doi: 10.1128/jvi.42.3.790-797.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Baczko, K., Billeter, M. & ter Meulen, V. J. gen. Virol. (in the press). [DOI] [PubMed]
  • 21.Herman CH, Schubert M, Keene JD, Lazzarini RA. Proc. natn. Acad. Sci. U.S.A. 1980;77:4662–4665. doi: 10.1073/pnas.77.8.4662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Barrett T, Wolstenholme AJ, Mahy BWJ. Virology. 1979;98:211–225. doi: 10.1016/0042-6822(79)90539-7. [DOI] [PubMed] [Google Scholar]
  • 23.Pelham HRB, Jackson RJ. Eur. J. Biochem. 1976;67:247–256. doi: 10.1111/j.1432-1033.1976.tb10656.x. [DOI] [PubMed] [Google Scholar]
  • 24.Thomas PS. Proc. natn. Acad. Sci. U.S.A. 1980;77:5201–5205. doi: 10.1073/pnas.77.9.5201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Cleveland DW, Fischer SG, Kirschner W, Laemmli UK. J. biol. Chem. 1977;252:1102–1106. [PubMed] [Google Scholar]

Articles from Nature are provided here courtesy of Nature Publishing Group

RESOURCES